| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae Proteins | 27 | 2024 | 285 | 6.470 |
Why?
|
| Meiosis | 22 | 2024 | 82 | 6.340 |
Why?
|
| Rad51 Recombinase | 28 | 2019 | 80 | 6.060 |
Why?
|
| Cell Cycle Proteins | 21 | 2024 | 401 | 5.540 |
Why?
|
| DNA-Binding Proteins | 32 | 2019 | 1241 | 5.380 |
Why?
|
| Saccharomyces cerevisiae | 30 | 2024 | 439 | 5.120 |
Why?
|
| Recombination, Genetic | 18 | 2024 | 444 | 2.730 |
Why?
|
| DNA, Single-Stranded | 13 | 2019 | 92 | 2.210 |
Why?
|
| Rec A Recombinases | 7 | 2021 | 14 | 2.200 |
Why?
|
| Homologous Recombination | 12 | 2024 | 52 | 2.090 |
Why?
|
| DNA Breaks, Double-Stranded | 7 | 2024 | 66 | 2.040 |
Why?
|
| Heart Transplantation | 14 | 2015 | 717 | 1.910 |
Why?
|
| Graft Rejection | 13 | 2015 | 1068 | 1.820 |
Why?
|
| DNA Repair | 19 | 2015 | 362 | 1.600 |
Why?
|
| DNA Helicases | 8 | 2018 | 84 | 1.540 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2019 | 59 | 1.520 |
Why?
|
| DNA | 8 | 2021 | 1307 | 1.470 |
Why?
|
| Crossing Over, Genetic | 8 | 2019 | 33 | 1.360 |
Why?
|
| Recombinases | 5 | 2019 | 21 | 1.270 |
Why?
|
| Adenosine Triphosphatases | 8 | 2021 | 154 | 1.250 |
Why?
|
| CD40 Ligand | 7 | 2013 | 69 | 1.160 |
Why?
|
| CD40 Antigens | 5 | 2013 | 44 | 1.130 |
Why?
|
| Recombinational DNA Repair | 2 | 2018 | 9 | 1.040 |
Why?
|
| Exodeoxyribonucleases | 2 | 2024 | 17 | 1.020 |
Why?
|
| Replication Protein A | 7 | 2019 | 16 | 1.010 |
Why?
|
| DNA Replication | 4 | 2019 | 170 | 0.970 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2024 | 26 | 0.970 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2024 | 39 | 0.960 |
Why?
|
| Graft Survival | 11 | 2015 | 899 | 0.920 |
Why?
|
| Adenosine Triphosphate | 3 | 2021 | 316 | 0.880 |
Why?
|
| DNA Topoisomerases | 4 | 2018 | 4 | 0.840 |
Why?
|
| Transforming Growth Factor beta | 3 | 2009 | 321 | 0.810 |
Why?
|
| DNA Damage | 12 | 2019 | 371 | 0.700 |
Why?
|
| Fungal Proteins | 6 | 2004 | 141 | 0.690 |
Why?
|
| Chromosomes, Fungal | 5 | 2019 | 15 | 0.670 |
Why?
|
| Transplantation, Homologous | 14 | 2015 | 996 | 0.660 |
Why?
|
| DNA, Fungal | 7 | 2019 | 58 | 0.650 |
Why?
|
| Nuclear Proteins | 6 | 2019 | 726 | 0.640 |
Why?
|
| Interleukin-17 | 2 | 2009 | 105 | 0.620 |
Why?
|
| Mice, Inbred BALB C | 14 | 2015 | 1088 | 0.580 |
Why?
|
| BRCA1 Protein | 4 | 2007 | 204 | 0.580 |
Why?
|
| Multiprotein Complexes | 3 | 2015 | 96 | 0.560 |
Why?
|
| Immune System | 1 | 2017 | 97 | 0.530 |
Why?
|
| Immunologic Techniques | 1 | 2015 | 26 | 0.520 |
Why?
|
| Models, Biological | 5 | 2019 | 1764 | 0.500 |
Why?
|
| Chromosome Pairing | 3 | 2015 | 4 | 0.490 |
Why?
|
| Antibodies, Monoclonal | 5 | 2013 | 1402 | 0.460 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2013 | 4 | 0.450 |
Why?
|
| Cisplatin | 6 | 2011 | 617 | 0.440 |
Why?
|
| Receptors, OX40 | 2 | 2011 | 4 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 14 | 2015 | 3211 | 0.420 |
Why?
|
| T-Lymphocytes | 4 | 2015 | 1224 | 0.420 |
Why?
|
| Mice | 20 | 2017 | 11743 | 0.420 |
Why?
|
| Genes, BRCA1 | 3 | 2007 | 192 | 0.410 |
Why?
|
| Animals | 31 | 2017 | 27330 | 0.410 |
Why?
|
| Nucleic Acid Conformation | 3 | 2019 | 339 | 0.400 |
Why?
|
| Microbiota | 1 | 2017 | 398 | 0.390 |
Why?
|
| DNA, Cruciform | 3 | 2007 | 5 | 0.390 |
Why?
|
| Calcium | 2 | 2014 | 1174 | 0.380 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2013 | 306 | 0.380 |
Why?
|
| Transplantation Tolerance | 4 | 2011 | 138 | 0.380 |
Why?
|
| DNA Repair Enzymes | 7 | 2015 | 55 | 0.370 |
Why?
|
| Synaptonemal Complex | 3 | 2015 | 4 | 0.370 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2019 | 387 | 0.370 |
Why?
|
| Interleukin-6 | 1 | 2011 | 261 | 0.360 |
Why?
|
| Cell Nucleus | 5 | 2010 | 599 | 0.360 |
Why?
|
| Hydrolysis | 2 | 2021 | 141 | 0.350 |
Why?
|
| Chickens | 6 | 2011 | 212 | 0.340 |
Why?
|
| Proteoglycans | 1 | 2009 | 123 | 0.330 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2009 | 127 | 0.330 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 751 | 0.320 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 428 | 0.320 |
Why?
|
| CD8 Antigens | 1 | 2008 | 82 | 0.320 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 445 | 0.320 |
Why?
|
| Mutation | 10 | 2019 | 4137 | 0.310 |
Why?
|
| Interferon-gamma | 7 | 2015 | 451 | 0.310 |
Why?
|
| Breast Neoplasms | 3 | 2008 | 3003 | 0.300 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2008 | 135 | 0.300 |
Why?
|
| Th1 Cells | 2 | 2009 | 166 | 0.300 |
Why?
|
| T-Box Domain Proteins | 1 | 2008 | 124 | 0.290 |
Why?
|
| Genes, BRCA2 | 1 | 2008 | 161 | 0.280 |
Why?
|
| Saccharomycetales | 1 | 2006 | 11 | 0.280 |
Why?
|
| Mitosis | 2 | 2010 | 152 | 0.270 |
Why?
|
| Signal Transduction | 5 | 2015 | 3376 | 0.270 |
Why?
|
| Schizosaccharomyces | 1 | 2006 | 55 | 0.270 |
Why?
|
| Chromatin | 3 | 2014 | 397 | 0.270 |
Why?
|
| Transfection | 3 | 2010 | 911 | 0.260 |
Why?
|
| Mice, Knockout | 8 | 2013 | 1990 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 887 | 0.250 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 153 | 0.250 |
Why?
|
| Models, Genetic | 5 | 2019 | 944 | 0.250 |
Why?
|
| Fibrosis | 3 | 2012 | 234 | 0.250 |
Why?
|
| Genes, Fungal | 2 | 2006 | 58 | 0.240 |
Why?
|
| Caffeine | 2 | 2015 | 83 | 0.240 |
Why?
|
| Protein Binding | 4 | 2018 | 1487 | 0.230 |
Why?
|
| Gene Conversion | 3 | 2015 | 24 | 0.230 |
Why?
|
| Biochemistry | 1 | 2004 | 28 | 0.230 |
Why?
|
| Reoperation | 1 | 2005 | 598 | 0.210 |
Why?
|
| Cell Proliferation | 6 | 2015 | 1650 | 0.210 |
Why?
|
| Neoplasms | 2 | 2015 | 3037 | 0.210 |
Why?
|
| Cross-Linking Reagents | 4 | 2012 | 87 | 0.210 |
Why?
|
| Models, Molecular | 3 | 2014 | 1296 | 0.210 |
Why?
|
| Protein Transport | 1 | 2004 | 421 | 0.200 |
Why?
|
| Nucleic Acid Renaturation | 1 | 2001 | 5 | 0.200 |
Why?
|
| DNA, Superhelical | 1 | 2001 | 17 | 0.200 |
Why?
|
| Transplantation Immunology | 1 | 2002 | 82 | 0.200 |
Why?
|
| Recombinant Proteins | 3 | 2018 | 1012 | 0.190 |
Why?
|
| Personnel Selection | 1 | 2021 | 60 | 0.190 |
Why?
|
| Neoplasm Proteins | 2 | 2001 | 540 | 0.190 |
Why?
|
| Dendritic Cells | 1 | 2004 | 442 | 0.180 |
Why?
|
| Benzamides | 2 | 2014 | 237 | 0.180 |
Why?
|
| Peptides | 1 | 2004 | 647 | 0.180 |
Why?
|
| Humans | 21 | 2021 | 89157 | 0.180 |
Why?
|
| X-Rays | 1 | 2000 | 134 | 0.180 |
Why?
|
| Th2 Cells | 2 | 2013 | 147 | 0.180 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2000 | 57 | 0.180 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 13 | 0.180 |
Why?
|
| BRCA2 Protein | 3 | 2011 | 161 | 0.180 |
Why?
|
| Suppression, Genetic | 1 | 1999 | 30 | 0.170 |
Why?
|
| Amino Acid Sequence | 3 | 2014 | 2062 | 0.170 |
Why?
|
| Protein Stability | 1 | 2019 | 100 | 0.170 |
Why?
|
| Sulfonamides | 2 | 2014 | 318 | 0.170 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 2553 | 0.170 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 3027 | 0.160 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 338 | 0.160 |
Why?
|
| Chromosome Segregation | 2 | 2019 | 32 | 0.160 |
Why?
|
| Chronic Disease | 3 | 2012 | 948 | 0.150 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2018 | 34 | 0.150 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 2 | 2007 | 4 | 0.150 |
Why?
|
| Escherichia coli | 2 | 2018 | 605 | 0.150 |
Why?
|
| MCF-7 Cells | 2 | 2015 | 114 | 0.150 |
Why?
|
| Transcription Factors | 3 | 2010 | 1652 | 0.150 |
Why?
|
| Base Pairing | 2 | 2008 | 56 | 0.150 |
Why?
|
| Germ-Free Life | 1 | 2017 | 75 | 0.140 |
Why?
|
| Base Sequence | 2 | 2014 | 2327 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 315 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2002 | 669 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 243 | 0.140 |
Why?
|
| Sister Chromatid Exchange | 1 | 2015 | 13 | 0.130 |
Why?
|
| Formaldehyde | 2 | 2007 | 52 | 0.130 |
Why?
|
| Immunity | 2 | 2015 | 141 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2015 | 595 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2009 | 727 | 0.130 |
Why?
|
| Endonucleases | 1 | 2015 | 23 | 0.130 |
Why?
|
| Mutagens | 1 | 2015 | 31 | 0.130 |
Why?
|
| Epistasis, Genetic | 3 | 2011 | 90 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2004 | 2412 | 0.120 |
Why?
|
| Female | 10 | 2012 | 46078 | 0.120 |
Why?
|
| Chromatids | 1 | 2013 | 7 | 0.120 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 268 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 120 | 0.120 |
Why?
|
| Time Factors | 5 | 2015 | 5331 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 181 | 0.120 |
Why?
|
| B-Lymphocytes | 2 | 2009 | 738 | 0.110 |
Why?
|
| S Phase | 2 | 2007 | 63 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 557 | 0.110 |
Why?
|
| Exons | 1 | 2014 | 451 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2012 | 96 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2015 | 691 | 0.100 |
Why?
|
| Morpholines | 1 | 2012 | 69 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 183 | 0.100 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 319 | 0.100 |
Why?
|
| Homeostasis | 1 | 2013 | 415 | 0.100 |
Why?
|
| Fibronectins | 1 | 2012 | 101 | 0.100 |
Why?
|
| Cell Survival | 4 | 2014 | 982 | 0.090 |
Why?
|
| Pyrroles | 1 | 2012 | 187 | 0.090 |
Why?
|
| Ku Autoantigen | 2 | 2007 | 12 | 0.090 |
Why?
|
| Antigens, Nuclear | 2 | 2007 | 25 | 0.090 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 253 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 282 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 576 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2011 | 291 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 504 | 0.090 |
Why?
|
| Decorin | 1 | 2009 | 6 | 0.090 |
Why?
|
| Interleukin-2 | 3 | 2011 | 251 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 160 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 171 | 0.080 |
Why?
|
| Spleen | 2 | 2012 | 432 | 0.080 |
Why?
|
| Transplantation, Heterotopic | 1 | 2009 | 46 | 0.080 |
Why?
|
| Granulocytes | 1 | 2009 | 38 | 0.080 |
Why?
|
| Coronary Thrombosis | 1 | 2009 | 14 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 645 | 0.080 |
Why?
|
| Protein Subunits | 2 | 2012 | 123 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2007 | 509 | 0.080 |
Why?
|
| Myocardium | 1 | 2012 | 571 | 0.080 |
Why?
|
| DNA, Circular | 1 | 2008 | 8 | 0.080 |
Why?
|
| Sciatic Nerve | 1 | 2008 | 34 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1215 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 136 | 0.080 |
Why?
|
| Small Molecule Libraries | 1 | 2008 | 65 | 0.080 |
Why?
|
| Disinfectants | 1 | 2007 | 8 | 0.080 |
Why?
|
| G2 Phase | 1 | 2007 | 34 | 0.080 |
Why?
|
| Endodeoxyribonucleases | 2 | 2015 | 11 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2008 | 80 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 85 | 0.070 |
Why?
|
| Cytidine Deaminase | 1 | 2007 | 43 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2008 | 616 | 0.070 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2007 | 109 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2012 | 2880 | 0.070 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2006 | 14 | 0.070 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 173 | 0.070 |
Why?
|
| Peroneal Nerve | 1 | 2006 | 9 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1521 | 0.070 |
Why?
|
| RNA, Double-Stranded | 1 | 2006 | 22 | 0.070 |
Why?
|
| RNA, Fungal | 1 | 2006 | 42 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 217 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2008 | 338 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2005 | 47 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1798 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2005 | 89 | 0.060 |
Why?
|
| Transgenes | 1 | 2005 | 185 | 0.060 |
Why?
|
| Cell Movement | 1 | 2009 | 783 | 0.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2005 | 138 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2006 | 171 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2006 | 277 | 0.060 |
Why?
|
| Bacteriophage M13 | 1 | 2004 | 9 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2005 | 349 | 0.060 |
Why?
|
| Respirovirus Infections | 1 | 2003 | 12 | 0.060 |
Why?
|
| Peptide Library | 1 | 2004 | 84 | 0.060 |
Why?
|
| Cytokines | 1 | 2008 | 802 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2015 | 511 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 308 | 0.060 |
Why?
|
| Chromosomes | 1 | 2004 | 97 | 0.060 |
Why?
|
| Receptors, Interleukin | 1 | 2003 | 36 | 0.060 |
Why?
|
| Binding Sites | 1 | 2006 | 1117 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2003 | 73 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2006 | 1130 | 0.060 |
Why?
|
| Macrophages, Alveolar | 1 | 2003 | 57 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2003 | 109 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2003 | 106 | 0.050 |
Why?
|
| Immunity, Cellular | 2 | 2015 | 178 | 0.050 |
Why?
|
| Bone Transplantation | 1 | 2003 | 66 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 565 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2003 | 151 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 1265 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 1239 | 0.050 |
Why?
|
| Exodeoxyribonuclease V | 1 | 2001 | 4 | 0.050 |
Why?
|
| Avian Proteins | 1 | 2001 | 19 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 116 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2001 | 44 | 0.050 |
Why?
|
| Catalysis | 1 | 2001 | 205 | 0.050 |
Why?
|
| Chick Embryo | 1 | 2001 | 230 | 0.050 |
Why?
|
| Gamma Rays | 2 | 2011 | 73 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2021 | 57 | 0.050 |
Why?
|
| Interleukin-4 | 2 | 2015 | 130 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2001 | 211 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2021 | 113 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 418 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 646 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2000 | 188 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 1975 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2003 | 370 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2011 | 342 | 0.040 |
Why?
|
| Mitomycin | 2 | 2012 | 29 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1574 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2011 | 0.040 |
Why?
|
| Gene Library | 1 | 1999 | 133 | 0.040 |
Why?
|
| Mutagenesis | 1 | 1999 | 202 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 112 | 0.040 |
Why?
|
| Plasmids | 1 | 1999 | 291 | 0.040 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 1998 | 1 | 0.040 |
Why?
|
| CHO Cells | 1 | 1998 | 187 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1998 | 177 | 0.040 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 1998 | 96 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1998 | 392 | 0.040 |
Why?
|
| Cricetinae | 1 | 1998 | 558 | 0.040 |
Why?
|
| Rabbits | 1 | 1998 | 638 | 0.040 |
Why?
|
| Gene Expression | 2 | 2012 | 1310 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 1940 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 2 | 2008 | 101 | 0.030 |
Why?
|
| Phylogeny | 1 | 2001 | 1183 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2015 | 51 | 0.030 |
Why?
|
| Immunochemistry | 1 | 1994 | 16 | 0.030 |
Why?
|
| Spores, Fungal | 1 | 1994 | 18 | 0.030 |
Why?
|
| Cell Line | 2 | 2011 | 2495 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 106 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1994 | 69 | 0.030 |
Why?
|
| Genotype | 1 | 1999 | 1848 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 66 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 121 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2015 | 123 | 0.030 |
Why?
|
| Epitopes | 1 | 1994 | 255 | 0.030 |
Why?
|
| Dimerization | 2 | 2004 | 143 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 1157 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 397 | 0.030 |
Why?
|
| Fluorometry | 1 | 2013 | 30 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 388 | 0.030 |
Why?
|
| Histones | 1 | 2015 | 329 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 313 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 376 | 0.030 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 95 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 814 | 0.030 |
Why?
|
| OX40 Ligand | 1 | 2011 | 1 | 0.030 |
Why?
|
| Tumor Necrosis Factors | 1 | 2011 | 14 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 2363 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 638 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2011 | 173 | 0.020 |
Why?
|
| Rotation | 1 | 2011 | 91 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 116 | 0.020 |
Why?
|
| Cysteine | 1 | 2012 | 136 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 2338 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 214 | 0.020 |
Why?
|
| Phthalazines | 1 | 2011 | 45 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 105 | 0.020 |
Why?
|
| Chromosomal Instability | 1 | 2010 | 19 | 0.020 |
Why?
|
| Diploidy | 1 | 2010 | 31 | 0.020 |
Why?
|
| Haploidy | 1 | 2010 | 32 | 0.020 |
Why?
|
| Camptothecin | 1 | 2011 | 193 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 244 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2012 | 190 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 253 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 390 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 841 | 0.020 |
Why?
|
| Piperazines | 1 | 2011 | 283 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 432 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2008 | 39 | 0.020 |
Why?
|
| Genome | 1 | 2011 | 386 | 0.020 |
Why?
|
| Glyoxal | 1 | 2007 | 1 | 0.020 |
Why?
|
| Acrolein | 1 | 2007 | 5 | 0.020 |
Why?
|
| Acetaldehyde | 1 | 2007 | 7 | 0.020 |
Why?
|
| Fanconi Anemia | 1 | 2007 | 9 | 0.020 |
Why?
|
| Pyruvaldehyde | 1 | 2007 | 10 | 0.020 |
Why?
|
| Aldehydes | 1 | 2007 | 19 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2007 | 129 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 163 | 0.020 |
Why?
|
| Glutathione | 1 | 2007 | 108 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 443 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2010 | 423 | 0.020 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2006 | 31 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 543 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 556 | 0.020 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2006 | 37 | 0.020 |
Why?
|
| Isometric Contraction | 1 | 2006 | 42 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 2006 | 36 | 0.020 |
Why?
|
| Genes, rev | 1 | 2005 | 1 | 0.020 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2005 | 4 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 24 | 0.020 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2005 | 16 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2007 | 794 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 464 | 0.020 |
Why?
|
| Bacteriophage phi X 174 | 1 | 2005 | 2 | 0.020 |
Why?
|
| Calcium Chloride | 1 | 2005 | 9 | 0.020 |
Why?
|
| Magnesium Chloride | 1 | 2005 | 6 | 0.020 |
Why?
|
| Chemistry, Physical | 1 | 2005 | 29 | 0.020 |
Why?
|
| Hindlimb | 1 | 2006 | 95 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2005 | 72 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2005 | 39 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2006 | 172 | 0.020 |
Why?
|
| Melphalan | 1 | 2005 | 98 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2005 | 53 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2008 | 755 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2005 | 262 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 2439 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 412 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 332 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2006 | 292 | 0.020 |
Why?
|
| Sendai virus | 1 | 2003 | 8 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 2003 | 14 | 0.010 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2003 | 12 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2003 | 20 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2003 | 21 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2006 | 232 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 344 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 90 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2003 | 110 | 0.010 |
Why?
|
| Immune Sera | 1 | 2003 | 52 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2003 | 205 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 2003 | 23 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 284 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1528 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 467 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 240 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 2479 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 371 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 519 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2003 | 466 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2003 | 184 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2003 | 491 | 0.010 |
Why?
|
| Male | 1 | 2006 | 42309 | 0.000 |
Why?
|